Volume 21, Issue 70 (11-2020)
Zanko J Med Sci 2020, 21(70): 69-71 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Payandeh M, Ahmadyani R, Karamian M H, Iranpanah A. Allogenic Bone Marrow Transplantation in an AML Patient with Cardiovascular Disease Background: A Case Study. Zanko J Med Sci 2020; 21 (70) :69-71
URL: http://zanko.muk.ac.ir/article-1-525-en.html
URL: http://zanko.muk.ac.ir/article-1-525-en.html
Students Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran
Abstract: (2058 Views)
Abstract
Acute myeloid leukemia (AML) is defined by increase in the number of myeloid cell lineages in peripheral blood. There are several established protocols for curing AML, each with its own limitations. This paper is a brief report on successful treatment of a middle-aged female AML patient with cardiovascular disease background, by using Allogenic Bone Marrow Transplantatin
Keywords: acute myeloid leukemia, bone marrow transplantation, heart failure, locus mismatch, case report
Type of Study: case report |
Subject:
Special
Received: 2020/09/4 | Accepted: 2020/10/1 | ePublished: 2020/12/30
Received: 2020/09/4 | Accepted: 2020/10/1 | ePublished: 2020/12/30
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
